NEW DELHI, Feb. 13 -- Johnson & Johnson (J&J) has pushed further into the robotics market after acquiring surgical robotics company Auris Health Inc. for around US$3.4bn.
The multi-billion-dollar deal will " accelerate Johnson & Johnson's entry into robotics with potential for growth and expansion into other interventional applications", the firm said in a statement.
Auris Health is a California-based privately-held firm that creates robotic technologies.
It is primarily focused on lung cancer, with its FDA-cleared platform currently being used in bronchoscopic diagnostic and therapeutic procedures.
SEE ALSO:
IBM teams up with Aetna, Anthem, HCSC and PNC Bank to create blockchain-based healthcare ecosystem
Walgreens partners with Micros...